# Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)

> **NCT02230059** · — · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 382 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT02230059
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 382 (ACTUAL)
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02230059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02230059, "Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02230059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*